Columbus Circle Capital Corp III 8-K

What Happened

• Columbus Circle Capital Corp III (CCCT) announced the closing of its initial public offering. The Registration Statement was declared effective July 8, 2026, and the IPO closed July 10, 2026. The Company sold 23,000,000 units at $10.00 per unit, generating $230,000,000 in gross proceeds. Each unit consists of one Class A ordinary share and one-third of one redeemable warrant; each full warrant converts to one Class A share at $11.50 per share.
• The Company also completed a simultaneous private sale of 665,000 identical private placement units (265,000 to the Sponsor and 400,000 to the Representatives) at $10.00 per unit for $6,650,000 in the aggregate. The Company entered into customary underwriting, warrant, trust, registration-rights, sponsor and other agreements in connection with the IPO.

Key Details

• IPO size & price: 23,000,000 units at $10.00 each = $230,000,000 gross proceeds (includes 3,000,000 units from full exercise of the underwriters’ over-allotment).
• Private placement: 665,000 units sold privately for $6,650,000 (Sponsor: 265,000; Representatives: 400,000); sold under Section 4(a)(2) exemption.
• Warrants: Each unit includes one‑third of a warrant; each full warrant exercisable for one Class A share at $11.50.
• Trust account & timing: $230,000,000 of proceeds were placed in a U.S.-based trust account; funds are restricted except for limited tax and wind‑up expenses until the earlier of (i) completion of an initial business combination, (ii) liquidation/redemption if no combination within 24 months, or (iii) certain shareholder-approved amendments.

Why It Matters

• For investors, the IPO establishes CCCT as a newly-listed blank-check (SPAC) vehicle with $230M held in trust to finance an initial business combination. The trust account provides capital protection until a qualifying deal or liquidation event.
• The private placement to the Sponsor and Representatives and the issued warrants affect the capital structure and potential dilution if warrants are exercised. The board appointments (four new directors, three designated independent) and the filed governance documents (amended articles, indemnity and letter agreements) set up oversight and sponsor arrangements that will govern CCCT as it seeks a target.